These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Beta-endorphin mediates clonidine stimulated growth hormone release.
    Author: Bruhn TO, Tresco PA, Mueller GP, Jackson IM.
    Journal: Neuroendocrinology; 1989 Oct; 50(4):460-3. PubMed ID: 2572990.
    Abstract:
    The role of beta-endorphin in the stimulation of growth hormone secretion elicited by administration of clonidine (Clon), an alpha2-adrenergic agonist, was investigated in awake, freely moving male rats. Animals were infused slowly with either 1 ml of normal rabbit serum (NRS), beta-endorphin antiserum (beta-end-AS) or ACTH antiserum (ACTH-AS) 2 h before the administration of Clon (100 microgram/kg body weight, intravenously). In addition, naloxone (Nal) (2.5 mg/kg body weight, intravenously) was given 15 min prior to Clon in some experiments. Blood samples were taken at 15-min intervals prior to and following Clon administration. Clon caused plasma GH levels to rise 15-fold to peak levels of 177 +/- 38 ng/ml (p less than 0.01) at 30 min. Pretreatment of both Nal or beta-end-AS significantly reduced Clon-stimulated GH secretion to 72 +/- 19 ng/ml (p less than 0.05) and 87 +/- 30 ng/ml (p less than 0.05) respectively. In contrast, the infusion of ACTH antiserum did not affect Clon-stimulated GH release. Our data suggest that beta-endorphin or a related opioid peptide is an important mediator of GH secretion induced by alpha2-adrenergic stimulation. Since blockade of opioid receptors blunted Clon-induced GH release only partially (approximately 50%), other mediators are most likely activated following alpha 2-adrenergic stimulation.
    [Abstract] [Full Text] [Related] [New Search]